An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bicycle Therapeutics plc (NASDAQ: BCYC) announced participation in several investor conferences during November and December 2021. These include the Jefferies London Healthcare Conference on November 19, Piper Sandler's Healthcare Conference on December 2, JMP Securities Hematology & Oncology Summit on December 6, and Jefferies Denver Healthcare Summit on December 15. Pre-recorded fireside chats will be available before each event, with webcasts accessible on the company’s website for 30 days following the chats.
Positive
None.
Negative
None.
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in November and December:
Jefferies London Healthcare Conference on Friday, November 19, 2021; pre-recorded fireside chat available on demand at 3:00 a.m. ET on Thursday, November 18, 2021
Piper Sandler 33rd Annual Healthcare Conference on Thursday, December 2, 2021; pre-recorded fireside chat available on demand at 10:00 a.m. ET on Monday, November 22, 2021
JMP Securities Hematology & Oncology Summit on Monday, December 6, 2021; fireside chat at 10:20 a.m. ET
Jefferies Denver Healthcare Summit on Wednesday, December 15, 2021
A live webcast and replay of pre-recorded fireside chats will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the fireside chat dates.
About Bicycle Therapeutics
Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC™) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICA targeting Nectin-4 and agonizing CD137, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the Cancer Research UK Centre for Drug Development. Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Lexington, MA. For more information, visit bicycletherapeutics.com.
What conferences is Bicycle Therapeutics (BCYC) participating in during November and December 2021?
Bicycle Therapeutics will participate in the Jefferies London Healthcare Conference, Piper Sandler's Healthcare Conference, JMP Securities Hematology & Oncology Summit, and Jefferies Denver Healthcare Summit.
When will the fireside chats for Bicycle Therapeutics (BCYC) be available?
Fireside chats for Bicycle Therapeutics will be available on November 18 for Jefferies, November 22 for Piper Sandler, and at their respective conference dates on December 6 and December 15.
Where can I access the webcasts of Bicycle Therapeutics (BCYC) investor conferences?
Webcasts of Bicycle Therapeutics' investor conferences can be accessed in the Investors & Media section of their website.
What is the focus of Bicycle Therapeutics (BCYC) as a biotechnology company?
Bicycle Therapeutics focuses on developing a novel class of therapeutics called Bicycles, which are designed for diseases that current treatments do not adequately address.
Bicycle Therapeutics plc American Depositary Shares
